Lytle Paul J

Lytle Paul J is listed in filings as Chief Financial Officer at Actuate Therapeutics Inc. This profile follows SEC Form 4 activity through Apr 1, 2026, including 3 public disclosures. Recent filings connect the profile to Actuate Therapeutics Inc (ACTU). The current snapshot covers public activity from Apr 2, 2025 to Apr 1, 2026. Reported amounts are shown as $261.4K to $280.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.